<?xml version="1.0" encoding="UTF-8" ?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
<url>
	<loc>https://aglaia-oncology.com/</loc>
	<lastmod>2024-01-10T08:54:24+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>1.0</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/about-aglaia/</loc>
	<lastmod>2025-10-13T09:18:46+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/</loc>
	<lastmod>2026-01-08T15:06:57+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/investments/</loc>
	<lastmod>2026-01-08T15:52:47+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/impact/</loc>
	<lastmod>2026-01-08T15:46:38+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/esg/</loc>
	<lastmod>2022-12-14T09:55:10+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/</loc>
	<lastmod>2025-11-06T09:34:05+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/archive/</loc>
	<lastmod>2021-01-27T10:32:59+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/contact/</loc>
	<lastmod>2024-05-06T16:02:47+01:00 </lastmod>
	<changefreq>never</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/privacy/</loc>
	<lastmod>2018-12-28T10:50:46+01:00 </lastmod>
	<changefreq>never</changefreq>
	<priority>0.2</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/genmab-as-acquires-aglaia-portfolio-company-merus-nv-in-us-8-billion-all-cash-transaction/</loc>
	<lastmod>2026-01-08T17:00:32+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/sapreme-appoints-experienced-industry-executives-dr-jeanne-bolger-and-dr-andre-hoekema-to-its-board-of-directors/</loc>
	<lastmod>2023-07-21T15:42:00+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/mimetas-and-yamaha-motor-sign-joint-marketing-agreement-to-advance-automated-human-disease-model-applications-for-drug-development/</loc>
	<lastmod>2023-11-29T11:41:35+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/news/mimetas-contributes-with-human-organ-on-chip-data-to-ind-application-by-argenx/</loc>
	<lastmod>2024-07-18T11:04:22+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/mark-krul/</loc>
	<lastmod>2023-06-05T09:42:06+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/karl-rothweiler/</loc>
	<lastmod>2023-06-05T09:42:49+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/eric-van-der-putten/</loc>
	<lastmod>2023-06-05T09:59:48+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/ernst-geutjes/</loc>
	<lastmod>2023-06-05T10:00:55+01:00 </lastmod>
	<changefreq>yearly</changefreq>
	<priority>0.5</priority>
</url>
<url>
	<loc>https://aglaia-oncology.com/team/folkert-van-cleef/</loc>
	<lastmod>2026-01-08T15:02:39+01:00 </lastmod>
	<changefreq>monthly</changefreq>
	<priority>0.5</priority>
</url>
</urlset>